Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Papathanasiou

Showing results (71-80 of 77) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 77 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2024
From rare events to systematic data collection: the RESCUED registry for sudden cardiac death in the young in GermanyRenaldas Barkauskas, Tina Jenewein, Stefanie Scheiper-Welling, et al.
ESC Heart Failure|November 6, 2024
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational studyRichard J Nies, Svenja Ney, Ingrid Kindermann, et al.
American Journal of Hematology|March 4, 2023
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study groupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
European Heart Journal|June 2, 2025
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosisChristian Nitsche, Stephan Dobner, Hannah R Rosenblum, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 26, 2026
Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysisDaniel Lavall, Katharina Knoll, Sebastian Spethmann, et al.
Pageof 8

Showing results (71-80 of 77) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 77 results.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|May 15, 2024
From rare events to systematic data collection: the RESCUED registry for sudden cardiac death in the young in GermanyRenaldas Barkauskas, Tina Jenewein, Stefanie Scheiper-Welling, et al.
ESC Heart Failure|November 6, 2024
Real-world characteristics and treatment of cardiac transthyretin amyloidosis: A multicentre, observational studyRichard J Nies, Svenja Ney, Ingrid Kindermann, et al.
American Journal of Hematology|March 4, 2023
Improved survival of patients with primary plasma cell leukemia with VRd or daratumumab-based quadruplets: A multicenter study by the Greek myeloma study groupEirini Katodritou, Efstathios Kastritis, Dimitra Dalampira, et al.
Frontiers in Medicine|October 30, 2023
Caplacizumab for immune thrombotic thrombocytopenic purpura: real-world multicenter dataEleni Gavriilaki, Emmanuel Nikolousis, Eudoxia-Evaggelia Koravou, et al.
Annals of Hematology|October 1, 2015
Lack of survival improvement with novel anti-myeloma agents for patients with multiple myeloma and central nervous system involvement: the Greek Myeloma Study Group experienceEirini Katodritou, Evangelos Terpos, Efstathios Kastritis, et al.
European Heart Journal|June 2, 2025
Cardiac transthyretin amyloidosis treatment improves outcomes after aortic valve replacement for severe stenosisChristian Nitsche, Stephan Dobner, Hannah R Rosenblum, et al.
Clinical Research in Cardiology : Official Journal of the German Cardiac Society|January 26, 2026
Current treatment decisions in cardiac transthyretin amyloidosis: a multicentre analysisDaniel Lavall, Katharina Knoll, Sebastian Spethmann, et al.
Pageof 8